Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome

摘要

PurposeWe evaluated the efficacy and safety of febuxostat, a non-purine xanthine oxidase inhibitor, used for prevention of hyperuricemia associated with tumor lysis syndrome (TLS).